These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6139394)

  • 21. Long acting phenothiazines and long term psychotic patients: the role of fluphenazine enanthate in treatment.
    Wintrob RM
    Dis Nerv Syst; 1970 Sep; 31():Suppl:50-62. PubMed ID: 4990944
    [No Abstract]   [Full Text] [Related]  

  • 22. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R
    Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445
    [No Abstract]   [Full Text] [Related]  

  • 23. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy with injectable fluphenazines.
    Ayd FJ
    Curr Psychiatr Ther; 1976; 16():177-89. PubMed ID: 991628
    [No Abstract]   [Full Text] [Related]  

  • 25. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W
    Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract]   [Full Text] [Related]  

  • 26. Fluphenazine: twelve years' experience.
    Ayd FJ
    Dis Nerv Syst; 1968 Nov; 29(11):744-7. PubMed ID: 5752634
    [No Abstract]   [Full Text] [Related]  

  • 27. A clinical evaluation of an injectable phenothiazine in the management of acute psychotic patients.
    Verster JP
    S Afr Med J; 1967 Jan; 41(4):83-4. PubMed ID: 5335781
    [No Abstract]   [Full Text] [Related]  

  • 28. Extrapyramidal symptoms in the course of fluphenazine treatment.
    Bastecký J; Vinar O; Taussigová D
    Act Nerv Super (Praha); 1972; 14(2):97-9. PubMed ID: 5040184
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of fluphenazine enanthate in an out-patient clinic.
    Kingstone E
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):413-6. PubMed ID: 4882607
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of schizophrenic psychoses with gamma-type endorphins].
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1963-9. PubMed ID: 6171738
    [No Abstract]   [Full Text] [Related]  

  • 31. The depot fluphenazines: a reappraisal after 10 years' clinical experience.
    Ayd FJ
    Am J Psychiatry; 1975 May; 132(5):491-500. PubMed ID: 1091162
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of resistant schizophrenics with extreme high dosage fluphenazine hydrochloride.
    Itil T; Keskiner A; Heinemann L; Han T; Gannon P; Hsu W
    Psychosomatics; 1970; 11(5):456-63. PubMed ID: 4919176
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
    Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR
    Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
    [No Abstract]   [Full Text] [Related]  

  • 34. Maintenance treatment of schizophrenia with long-acting fluphenazine.
    Niturad A; Ciurezu T; Cucu I
    Act Nerv Super (Praha); 1974 Aug; 16(3):167. PubMed ID: 4154028
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long-action neuroleptic agents (delayed-action neuroleptics)].
    Ginestet D; Péron-Magnan P
    Rev Prat; 1972 Apr; 22(12):1941-53. PubMed ID: 4675045
    [No Abstract]   [Full Text] [Related]  

  • 36. Costs and benefits of two doses of fluphenazine.
    Marder SR; Van Putten T; Mintz J; McKenzie J; Lebell M; Faltico G; May PR
    Arch Gen Psychiatry; 1984 Nov; 41(11):1025-9. PubMed ID: 6437365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluphenazine enanthate: a report of a clinical trial in psychotic patients.
    Karkalas Y
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):196-200. PubMed ID: 4967873
    [No Abstract]   [Full Text] [Related]  

  • 38. Piperidine in chronic schizophrenic patients: a controlled double-blind study.
    Luchins DJ; Gillin JC; Wagner RL; DeLisi LE; Morihisa JM; Weinberger DR; Bigelow LB; Klein ST; Wyatt RJ
    Biol Psychiatry; 1981 Jan; 16(1):91-5. PubMed ID: 6112021
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of the action of fluphenazine oenanthate and decanoate in chronic psychoses (73 cases)].
    Martin A; Masson JM; Quentin JC; Verrier JP; Jusseaume P
    Ann Med Psychol (Paris); 1972 Dec; 2(5):705-8. PubMed ID: 4576210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.